SafetyDrugs

SafetyDrugs is a Pharmacovigilance database powered by Oracle, designed for small and medium companies. SD offers a complete suite of validation documents.

[SafetyDrugs @SafetyDrugs]

The proposed amendment to the #MDR introduces targeted measures that have a direct impact on #vigilance and #postmarketsurveillance.
In this article, we analyse what changes at an operational level.
👉 https://t.co/QbZpgH7I8w

[SafetyDrugs @SafetyDrugs]

SD Colletion, SafetyDrugs’ annual magazine, is now available on our website. https://t.co/EVpRkVzm5F

[SafetyDrugs @SafetyDrugs]

#MedDRA 28.1 is now the official reference version.
As outlined by international best practices, the release was implemented on the first Monday of November.
But what has actually changed for #pharmacovigilance professionals?
👉 Find it out here: https://t.co/3B40bFmh3B

[SafetyDrugs @SafetyDrugs]

#GVP Module VI Addendum II introduces new rules for #ICSRs submission to #EudraVigilance. Here it is what changes for #pharmacovigilance and how to manage compliance without operational complications, thanks to our #GDPR module.
https://t.co/7DTtqlbZci

[SafetyDrugs @SafetyDrugs]

What are the current limitations of #RiskCommunication in #pharmacovigilance?
At the AFI Symposium 2025, a new project was presented to rethink how educational materials and Direct Healthcare Professional Communications are managed in Italy.
https://t.co/VGP6X8lZRK

[SafetyDrugs @SafetyDrugs]

Quali sono oggi i limiti della #ComunicazioneDelRischio in #farmacovigilanza?
Dal Simposio AFI arriva un progetto che ripensa in chiave moderna la gestione dei #MaterialiEducazionali e delle #NoteInformativeImportanti: "Rethink Safety Communication". https://t.co/ocvp0ot1gW

[SafetyDrugs @SafetyDrugs]

We certified our processes according to the international ISO 27001 standard. Read the article to know why and what changes are for our clients. https://t.co/UJj1wUJv8O

[SafetyDrugs @SafetyDrugs]

Tra pochi giorni il mondo farmaceutico si incontrerà a Rimini per il 64° #SimposioAFI, dall’11 al 13 giugno.
Ci trovi allo stand 145. Sarà l’occasione perfetta per parlare di come #SafetyDrugs rende più semplici, efficaci e sicuri i tuoi processi di #farmacovigilanza.

[SafetyDrugs @SafetyDrugs]

#MedDRA 28.0 is now the official reference version.
We’ve published an article highlighting the most relevant structural changes — a clear and practical guide designed for those who work with MedDRA every day. https://t.co/Y1KHWsUM1p
#Pharmacovigilance #DrugSafety #ICSR

[SafetyDrugs @SafetyDrugs]

#MedDRA V.28.0 has just been released and we are preparing to load it into our clients' #SafetyDrugs systems. In the meantime, we have published an article dedicated to the structure and operational value of MedDRA in #pharmacovigilance
https://t.co/LSrbkp767c

[SafetyDrugs @SafetyDrugs]

#Thalidomide became one of the greatest pharmaceutical tragedies in history, a case that shocked public opinion and led to the creation of modern #pharmacovigilance. Read the full story 👉https://t.co/32u8K133gn
#DrugSafety

[SafetyDrugs @SafetyDrugs]

🔍 SD Collection 2025 is online, our end-of-year magazine with insights, updates and useful tips on pharmacovigilance.
👉 Read the full magazine https://t.co/5XN27btqtm

[SafetyDrugs @SafetyDrugs]

📖 È online SD Collection 2025, il nostro speciale di fine anno con approfondimenti, aggiornamenti e consigli utili sulla farmacovigilanza!
👉 Leggi il magazine completo qui: https://t.co/YyTYTOgvhQ

[SafetyDrugs @SafetyDrugs]

La gestione dei fondi di #farmacovigilanza diventa più efficiente grazie alla nuova piattaforma #AIFA. Le Regioni potranno ora monitorare meglio le risorse, migliorando la sicurezza e la trasparenza dei processi. Scopri di più leggendo l'articolo.
https://t.co/EwokgBpoJP

[SafetyDrugs @SafetyDrugs]

#Pharmacovigilance is a fundamental activity to ensure drug safety globally. In a constant effort to raise awareness about the importance of this practice, we have collected and answered the FAQ related to pharmacovigilance. Visit the page to read it. https://t.co/btDhvMuPSK

[SafetyDrugs @SafetyDrugs]

#AIFA is making strides in promoting #drugsafety. The recent announcement by the new Board of Directors concerns a significant commitment of funds, approximately 5 million euros, for #pharmacovigilance projects. https://t.co/x9dnIJcrJG

[SafetyDrugs @SafetyDrugs]

SD Collection 2024, the SafetyDrugs magazine with insights, updates and useful tips about pharmacovigilance is now available.
Read it now: https://t.co/3d3d06LW8v
#pharmacovigilance #drugsafety #safetydrugs #safetydatabase #signalmanagement #signaldetection

[SafetyDrugs @SafetyDrugs]

Protecting #pharmacovigilance data is a fundamental element for pharmaceutical companies. This is why for years we have relied on technological partner #Oracle to guarantee #SafetyDrugs users the maximum safety requirements. https://t.co/mlxLPhu8EB

[SafetyDrugs @SafetyDrugs]

#Pharmacovigilance #ICSR management is an essential activity. The #safetydatabase it's a fundamental ally in carrying out this activity. We have identified 10 advantages of its use. Read the article to discover them all. https://t.co/KJFZ9Kaigg

[SafetyDrugs @SafetyDrugs]

The #ICSRs transfer outside of EU poses several risks in terms of #GDPR compliance, as highlighted by #EMA. #SafetyDrugs' new module offers a key solution to simplify compliance. Find out more by reading the article.
#pharmacovigilance #safetydatabase
https://t.co/pJ7H7TMHtZ